Differential effects of intermittent and continuous administration of parathyroid hormone on bone histomorphometry and gene expression

By Lotinun Sutada   Sibonga Jean   Turner Russell  

Endocrine Journal, Vol. 17, Iss. 1, 2002-02 ,pp. : 29-36

Humana Press, Inc

Access to resources Recommend Favorite

Sequential Treatment with Intermittent Low-Dose Human Parathyroid Hormone (1-34) and Bisphosphonate Enhances Large-Size Skeletal Reconstruction by Vascularized Bone Transplantation

By Hashimoto Takahiro   Shigetomi Mitsunori   Ohno Teruyasu   Matsunaga Tsunemitsu   Muramatsu Keiichi   Tanaka Hiroshi   Sugiyama Toshihiro   Taguchi Toshihiko  

Calcified Tissue International, Vol. 81, Iss. 3, 2007-09 ,pp. : 232-239

Springer Publishing Company

Access to resources Recommend Favorite

Circulating Fibroblast Growth Factor 23 Increases Following Intermittent Parathyroid Hormone (1–34) in Postmenopausal Osteoporosis: Association with Biomarker of Bone Formation

By Mahon James  

Calcified Tissue International, Vol. 88, Iss. 6, 2011-06 ,pp. : 530-530

Springer Publishing Company

Access to resources Recommend Favorite

Circulating Fibroblast Growth Factor-23 Increases Following Intermittent Parathyroid Hormone (1–34) in Postmenopausal Osteoporosis: Association with Biomarker of Bone Formation

By Hampson Geeta  

Calcified Tissue International, Vol. 88, Iss. 6, 2011-06 ,pp. : 531-531

Springer Publishing Company

Access to resources Recommend Favorite

Circulating Fibroblast Growth Factor-23 Increases Following Intermittent Parathyroid Hormone (1–34) in Postmenopausal Osteoporosis: Association with Biomarker of Bone Formation

By Sridharan M.   Cheung J.   Moore A.   Frost M.   Fraser W.   Fogelman I.   Hampson G.  

Calcified Tissue International, Vol. 87, Iss. 5, 2010-11 ,pp. : 398-405

Springer Publishing Company

Access to resources Recommend Favorite